We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ININ
651
DELISTED
Interactive Intelligence Group, inc.
ININ
$84.4M 0.02%
1,897,634
-329,300
-15% -$14.6M
AVAL icon
652
Grupo Aval
AVAL
$6.41B
$84.4M 0.02%
8,617,610
+1,021,661
+13% +$10M
EIX icon
653
Edison International
EIX
$27.2B
$84.2M 0.02%
1,515,518
+943,245
+165% +$56.7M
MGRC icon
654
McGrath RentCorp
MGRC
$2.94B
$84.2M 0.02%
2,766,910
-144,147
-5% -$4.63M
JACK icon
655
Jack in the Box
JACK
$358M
$83.9M 0.02%
951,170
+8,480
+0.9% +$762K
AA icon
656
Alcoa
AA
$13.1B
$83.8M 0.02%
3,129,027
+2,659
+0.1% +$82.4K
SYT
657
DELISTED
Syngenta Ag
SYT
$83.5M 0.02%
+1,023,407
New +$82.3M
ALOG
658
DELISTED
Analogic Corp
ALOG
$83M 0.02%
1,051,602
-37,360
-3% -$3.16M
LHO
659
DELISTED
LaSalle Hotel Properties
LHO
$82.6M 0.02%
2,330,287
+7,310
+0.3% +$270K
RES icon
660
RPC Inc
RES
$1.39B
$82.5M 0.02%
5,965,125
+5,678,800
+1,983% +$83.8M
FOLD
661
DELISTED
Amicus Therapeutics
FOLD
$82.4M 0.02%
5,824,300
+5,203,051
+838% +$62.6M
FTK icon
662
Flotek Industries
FTK
$1.25B
$82M 0.02%
1,091,112
+2,095
+0.2% +$170K
APD icon
663
Air Products & Chemicals
APD
$68B
$81.6M 0.02%
644,284
-127,563
-17% -$17.4M
SPSC icon
664
SPS Commerce
SPSC
$2.86B
$81.1M 0.02%
2,463,788
-376,466
-13% -$12.7M
LCII icon
665
LCI Industries
LCII
$2.6B
$81M 0.02%
1,396,730
-8,000
-0.6% -$477K
TNGO
666
DELISTED
Tangoe, Inc.
TNGO
$81M 0.02%
6,437,020
-50,700
-0.8% -$681K
HSNI
667
DELISTED
HSN, Inc.
HSNI
$80.7M 0.02%
1,150,194
+35,620
+3% +$2.4M
SNX icon
668
TD Synnex
SNX
$20.4B
$80.6M 0.02%
2,201,260
-76,960
-3% -$3.06M
APAM icon
669
Artisan Partners
APAM
$3.03B
$79.7M 0.02%
1,715,940
+127,400
+8% +$5.83M
COLB icon
670
Columbia Banking Systems
COLB
$9.18B
$79.7M 0.02%
2,449,770
+310,260
+15% +$9.46M
BVN icon
671
Compañía de Minas Buenaventura
BVN
$8.55B
$79.6M 0.02%
7,668,148
+669,480
+10% +$7.33M
GD icon
672
General Dynamics
GD
$106B
$79.3M 0.02%
559,404
+22,690
+4% +$3.15M
ICPT
673
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$79.2M 0.02%
328,303
-76,784
-19% -$20.4M
LTRPA
674
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$79.2M 0.02%
2,456,614
+39,560
+2% +$1.2M
HP icon
675
Helmerich & Payne
HP
$4.3B
$79.1M 0.02%
1,123,846
+755,020
+205% +$55.8M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.